General MedicationsORALGeneric

ORINASE

TOLBUTAMIDE

Standard Dose

500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview ORINASE is listed in Drugs@FDA under application 010670 (NDA).

Marketing status: Discontinued Active ingredient TOLBUTAMIDE Form and strength TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 1987-10-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview ORINASE is listed in Drugs@FDA under application 010670 (NDA). Marketing status: Discontinued Active ingredient TOLBUTAMIDE Form and strength TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 1987-10-27 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.